Person · CIK 2154197

Julie Saiki

Chief Strategy Officer at Adial Pharmaceuticals

Source: Forms 3, 4, 5 and 144 on SEC EDGAR

Sold on Form 4$0
Noticed on Form 144$0
Bought on Form 4$0
Companies1

Holdings now

As reported after the latest Form 3, 4 or 5 at each company.

How these figures work

Options and RSUs are from the latest filing that lists them; earlier grants may also be held. Holdings can be out of date when a person stops filing.

CompanySecurityHeldShares or unitsAs of
Adial Pharmaceuticals ADILCommon StockDirectly62,665Oct 28, 2026 · Filing · EDGAR
Adial Pharmaceuticals ADILSeries A Preferred Stock
into Common Stock
Directly1,852,229Oct 28, 2026 · Filing · EDGAR
Adial Pharmaceuticals ADILStock Option (right to buy)
exercise $2.98, expires Jun 12, 2036, into Common Stock
Directly72,719Oct 28, 2026 · Filing · EDGAR
Adial Pharmaceuticals ADILStock Option (Right to Buy)
exercise $0.63, expires Apr 20, 2036, into Common Stock
Directly67,021Oct 28, 2026 · Filing · EDGAR
Adial Pharmaceuticals ADILStock Option (Right to Buy)
exercise $1.57, expires Nov 21, 2033, into Common Stock
Directly31,915Oct 28, 2026 · Filing · EDGAR

Sold and noticed by quarter

No sales or Form 144 notices with a stated value.

Every transaction, by company

Each Form 3, 4 and 5 transaction in plain words, newest first.

How these figures work

Values are shares times the price each filing states; grants, exercises and gifts usually state no price. Held after is what the filing reports was held once the transaction was done, directly or through the named holder.

Adial Pharmaceuticals ADIL Chief Strategy Officer · filings 2026 to 2026

No transactions in the filings read; Form 144 notices are listed above.

All 1 Forms 3, 4, 5 and 144
FiledFormCompanyLinks
Oct 30, 2026Form 3Adial Pharmaceuticals ADILFiling · EDGAR

Every figure is as filed with the SEC on Forms 3, 4, 5 and 144. Holdings are the amounts reported after each person's latest filing at each company and can be out of date. Matching a Form 144 notice to Form 4 sales is SEC Tracker's inference from owner, company, dates and share counts, not something the filings state. Not investment advice. Not affiliated with the U.S. SEC.